Directory → Neurotropic funds → Neiroleptiki → Haloperidol decanoate
This page is translated automatically with a help of Google Translate

Haloperidol decanoate

See also Haloperidol

Roman name

Haloperidol decanoate

The composition and the form of

Solution for injection oil-1 mlgaloperidol-50 megawatts sealed dark glass to 1 ml; In the box five vials.

Characteristics

The drug prolonged action.

Pharmacokinetics

Permanent concentration in the blood is achieved with the introduction of a period of 2-3 months.

Farmakodinamika

And protivosudorojnam, antipyretic and analgezirutm effects. In a single act of about 4 weeks.

Indications

Schizophrenia (maintenance therapy).

Pregnancy and lactation

Contraindicated. At the time of treatment should stop breastfeeding.

Contraindications

Neurological diseases with the pyramid and ekstrapiramidna symptoms, pregnancy, breast-feeding.

Side-Effects

Drowsiness, ekstrapiramidnye violation (akinesia, the symptoms parkinsonizma, diskinesia later), depression.

Patient interaction

Do effect gipotenziveh drugs, barbiturates, narcotic analgesics, antidepressants, and alcohol; Weakens indirect anticoagulants.

Precautions

The special care unit picked sick elderly. Before you assign patients receiving anticoagulants proximity should reconsider their dose. There is a need to refrain from activities requiring greater attention.

Dosing and Administration

V / m, a unique mode. Normal initial dose, 75 mg every 4 weeks. Further dose of the drug can be gradually increased to 50 mg to achieve an optimal effect.

Storage conditions

List B. In the dark place at a temperature of 15-30 ° C

Shelf life

5 years

The registration

015065/01-2003

All products of this group

0